IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $605,564 | +108.5% | 15,774 | +3.0% | 0.00% | 0.0% |
| Q2 2023 | $290,507 | +32.5% | 15,314 | +8.3% | 0.00% | 0.0% |
| Q1 2023 | $219,218 | -12.6% | 14,134 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $250,879 | +217.6% | 14,134 | 0.0% | 0.00% | – |
| Q3 2022 | $79,000 | +43.6% | 14,134 | 0.0% | 0.00% | – |
| Q2 2022 | $55,000 | -29.5% | 14,134 | +0.1% | 0.00% | – |
| Q1 2022 | $78,000 | -35.0% | 14,124 | 0.0% | 0.00% | – |
| Q4 2021 | $120,000 | -0.8% | 14,124 | +1.2% | 0.00% | – |
| Q3 2021 | $121,000 | -18.2% | 13,962 | 0.0% | 0.00% | – |
| Q2 2021 | $148,000 | -31.5% | 13,962 | +3.9% | 0.00% | – |
| Q1 2021 | $216,000 | -65.2% | 13,436 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $621,000 | +176.0% | 13,436 | +110.1% | 0.00% | 0.0% |
| Q3 2020 | $225,000 | – | 6,396 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 1,818,371 | $69,807,263 | 24.57% |
| Alpine Global Management, LLC | 1,252,474 | $48,082,477 | 12.15% |
| Logos Global Management LP | 1,600,000 | $61,424,000 | 8.20% |
| Octagon Capital Advisors LP | 1,000,000 | $38,390,000 | 5.90% |
| Perceptive Advisors | 3,814,691 | $146,445,987 | 4.88% |
| COMMODORE CAPITAL LP | 1,000,000 | $38,390,000 | 4.49% |
| Deep Track Capital, LP | 2,797,955 | $107,413,492 | 4.15% |
| Fairmount Funds Management LLC | 750,000 | $28,792,500 | 3.46% |
| Ikarian Capital, LLC | 7,230 | $27,755,970 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 129,000 | $4,952,310 | 3.32% |